Background 
During a mass casualty or nuclear event, the surge in need for blood may exceed the existing supply. Platelets are of particular interest as a large number of platelets is anticipated to be needed in the case of a nuclear event. Apheresis-derived platelets have traditionally been the primary source for platelet transfusions in the United States (U.S.). In a crisis situation, whole blood-derived platelets can be scaled up to supplement the apheresis platelet supply. At least one blood center has modeled its flex capacity to produce platelets in response to crisis situations using an automated whole blood processing system.

Thank you to TerumoBCT for contributing this resource

Publish Date / Last Revised
June 24, 2025
Search Resources